Tetrabenazine Metabolite [(-)-β-Dihydrotetrabenazine; (-)-β-HTBZ], an active metabolite of Tetrabenazine, is a vesicular monoamine transporter 2 (VMAT2) inhibitor with a high affinity (Ki=13.4 nM). Tetrabenazine Metabolite is be developed for the treatment of chorea associated with Huntington’s disease and other hyperkinetic disorders.

纯度：≥98%

CAS：924854-60-4